Contact Information

Website: Heart Surgery

Request an Appointment

Call: 270-417-7510

Request an Appointment Online

Locations

Fady S. Wanna

Fady S. Wanna, MD

Request an Appointment Online
Specializing in Cardiothoracic Surgery
  • One Health

About

Education & Training

Education

  • Emory Goizueta Business School, Atlanta, Master of Business Administration
  • University of California, Irvine, School of Medicine

Residency

  • University of California, San Francisco – East Bay, General Surgery
  • Emory University, Atlanta, Cardiothoracic Surgery

Fellowship

  • Lawrence Berkeley Laboratory, California
  • Children’s Hospital Oakland, California, Cardiothoracic Research

Internships

  • University of California, San Francisco – East Bay, General Surgery

Professional Memberships

American College of Surgeons – Associate Fellow American Medical Association

Honors, Awards, etc.

Cum Laude, University of California San Diego, 1985

Phi Lambda Upsilon (Natl. Chem. Hon. Soc.), 1985

Lartigua Scholarship for Outstanding Merit, 1989

Board Certified

American Board of Surgery

American Board of Thoracic Surgery

Research Interest

Studies

MEND/CABG Trial; “A Randomized, Double Blind, Placebo Controlled Multi-Center Study to evaluate the Cardio-Protective effects of MC-1 in patients undergoing high risk coronary artery bypass graft (CABG) Surgery 

The Effect of Acadesine on Clinically Significant Adverse Cardiovascular and Cerebrovascular Events in High-Risk Subjects Undergoing Coronary Artery Bypass Graft Surgery Using Cardiopulmonary Bypass (Protocol No. PO5633): RED-CABG Trial (Reduction in Cardiovascular Events in Subjects Undergoing CABG)

SELECT CABG: A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Tolerability of 20mg/kg Dose of RO4905417 Administered Every Four Weeks for 32 weeks in Patients Undergoing Coronary Artery Bypass Surgery (CABG)

AKI AWARE  (Protocol No. M13-796) A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery 

Grants

Medical scientist, National Institute of Health, Program Project Grant (No 5), “In vitro cardiac metabolism using NMR and PET

Grant No - 1R41HL121919-01 Electronically releasable temporary cardiac pacing wire

Publications

Wanna FS, Kamal A. Mansour Extended resection of bronchial carcinoma in the superior pulmonary sulcus. In Thomas W. Shields (ed): General Thoracic Surgery, fifth edition. (In press)

Wanna FS, Kamal A. Mansour Esophageal Cancer (review article). In CA (J. of the Am Cancer Society). (In press)

Wanna FS
Book Review: Minimally Invasive Cardio Surgery, edited by Robbin G. Cohen, Michael J. Mack, James D. Fonger, and Rodney J. Landreneau, St Louis, MO, Quality Medical Publishing Inc, 1999. In Archives of Surgery, 1999; 134(10): 1155    

Young JN, Choy IO, Wanna FS, DeCampli WM.
Pediatric myocardial protection: A prospective randomized controlled clinical trial of blood versus crystalloid cardioplegia. Circulation, 1996; 94(8) Suppl. 1: I-480

Wanna FS, Schepkin VD, Young JN, Budinger TF, Decampli WM. Simultaneous manipulation of the nitric oxide and the prostanoid pathways reduces myocardial reperfusion injury. J. Thorac. Cardiovasc. Surg., 1995; 110: 1054-1062

Wanna FS, Schepkin VD, Young NJ, Budinger Tf, DeCampi WM. Effects of single oxygen and its scavenger (tryptophan) on bioenergetics and the recovery of the ischemic myocardium, American College of Surgeons 81st Clinical Congress, October 22, 1995.

Wanna FS, Young JN, DeCampli WM. Nirtric oxide and the prostaglandin pathways, old concepts—New understanding. Presented, Society of University Surgeons Thirty-First Annual Meeting, February 1995.

Decampli WM, Wanna FS, Young JN. L-arginine and aspirin--Surprising synergism in improving myocardial recovery following ischemia. Annuals of Thoracic Surgery, 1995; 60(3).